Topical cannabis extract for eczema itch
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a cannabis-based cream on eczema-related itch over 4 weeks. It may help reduce itching if other treatments haven't worked, but requires pausing other skin products during the trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 25 years or older.
- You have eczema (including atopic dermatitis, nummular eczema, lichen simplex chronicus, or prurigo nodularis) with itching that has lasted more than 6 weeks.
- You are willing to stop using all other skin creams and ointments for the 4-week study period.
- You have not used oral steroids, immune-suppressing drugs, or light therapy in the past 3 months.
- You do not have serious health conditions like kidney disease, liver cirrhosis, cancer, thyroid disease, or unstable heart or lung disease.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether acupuncture can help reduce itching and improve symptoms in adults with moderate to severe atopic dermatitis (eczema). It may offer a non-drug option for managing this condition.
This study tests whether roflumilast cream (a new anti-inflammatory medication applied to the skin) can reduce the intense itching caused by atopic dermatitis (eczema). You'll track your itching daily using a smartphone app and visit the clinic to see if the cream helps over time.
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.
This study tests a new ointment containing probiotics (good bacteria) to see if it helps with eczema in children. It is a cream that is applied to the skin, and the goal is to see if it reduces the itching and redness.
This study tests an investigational cream for moderate to severe eczema. It helps see if the cream reduces symptoms like itching and skin inflammation.
Hear when a new Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.